 |
Trial Information
Summary: New drug research study open to migraine and persistent headache sufferersAs a service to headache sufferers, NHF is distributing information about a drug research study taking place in many areas of the country. This drug is being conducted by a major pharmaceutical company and is not one in which the National Headache Foundation has an active part. We believe this notice may be useful to headache sufferers who wish to inquire about participating. Physicians conducting the study have begun testing an investigational drug to determine its safety and effectiveness for migraines and/or persistent headaches. To be eligible for this study, participants:
To learn more about this study and whether you qualify to participate,
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received. This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Trial listings updated: June 1, 2008 at 5:43:18 AM |
|
|
Patient Resources: [ Trial Listing
] [ Notification Services ] [ Drug
Directories ]
Copyright © 1995 - 2008, CenterWatch |
